Araştırma Makalesi

The Effect of Thiol-Disulfide Homeostasis on Prognosis in Patients with Early-Stage Non-Small Cell Lung Cancer

Cilt: 8 Sayı: 1 5 Mart 2023
PDF İndir
EN TR

The Effect of Thiol-Disulfide Homeostasis on Prognosis in Patients with Early-Stage Non-Small Cell Lung Cancer

Öz

Objective: Lung cancer has a poor prognosis. Thiol groups with high antioxidant capacity are converted to disulfide bonds through biochemical reactions that neutralize different oxidant compounds. The thiol-disulfide (SH-SS) homeostasis has significant effects on cell mechanisms, transcription, and apoptosis. Here we present the prognostic role of dynamic SH-SS homeostasis in patients operated for NSCLC. Materials and Methods: Patients operating for early-stage NSCLC were prospectively analyzed. SH-SS homeostasis tests were measured using the automated spectrophotometric method. Results: This study enrolled 138 subjects, including 77 patients and 61 healthy controls. Native thiol and total thiol levels were significantly lower in the patient group. The disulfide-to-native thiol ratio, which is an indicator of oxidative stress in SH-SS homeostasis, also reached a level of statistical significance in the patient group (p<0.001). According to the cut-off values (305 and 326.3), the median overall survival rate was significantly shorter in patients with low native thiol and total thiol levels (p<0.001). Conclusions: This study demonstrated decreased native thiol and total thiol levels as well as decreased disulfide levels and SS/SH ratio in early-stage NSCLC. Impaired SH-SS homeostasis may contribute to lung cancer pathogenesis and poor prognosis because of enhanced oxidative stress.

Anahtar Kelimeler

Kaynakça

  1. 1. Şener MU, Sönmez Ö, Keyf İA, et al. Evaluation of Thiol/Disulfide Homeostasis in Lung Cancer. Turk Thorac J. 2020;21(4):255-260. doi: 10.5152/TurkThoracJ.2019.19033
  2. 2. Useros JM, Weiyao L, Morales MC, Foncillas JG. Oxidative Stress: A New Target for Pancreatic Cancer Prognosis and Treatment. J Clin Med. 2017;9;6(3):1-16. doi: 10.3390/jcm6030029.
  3. 3. Erenler AK, Yardan T. Clinical Utility of Thiol/Disulfide Homeostasis. Clin Lab. 2017; 63(5):867-870. doi: 10.7754/Clin.Lab.2017.161117
  4. 4. Erel O, Neselioglu S. A novel and automated assay for thiol/disulfide homeostasis. Clin Biochem. 2014;47(18):326–332.
  5. 5. Yazicioglu A, Ergin M, Koca C, Yekeler E, Erel O, Karaoglanoglu N. Does intrapleural sericin administration have an effect on rat plasma thiol disulfide redox homeostasis in accordance with antioxidative functions or cancer preventive features. Sch J App Med Sci. 2017;5(2C):476-482.
  6. 6. Beyoglu, MA, Sahin MF, Turkkan S, et al. Dynamic Thiol-Disulfide Homeostasis in Lung Transplant Recipients. Exp Clin Transplant. 2022; Online ahead of print. doi:10.6002/ect.2021.0360.
  7. 7. Demirseren DD, Cicek C, Alisik M, Demirseren ME, Aktaş A, Erel O. Dynamic thiol/disulfide homeostasis in patients with basal cell carcinoma. Cutan Ocul Toxicol. 2017;1:1-5.
  8. 8. Otal Y, Kahraman FA, Haydar FG, Erel Ö. Dynamic thiol/disulfide homeostasis as oxidative stress marker in diabetic ketoacidosis. Turk J Med Sci. 2021;51:743-748.

Ayrıntılar

Birincil Dil

İngilizce

Konular

Sağlık Kurumları Yönetimi

Bölüm

Araştırma Makalesi

Yayımlanma Tarihi

5 Mart 2023

Gönderilme Tarihi

30 Aralık 2022

Kabul Tarihi

5 Şubat 2023

Yayımlandığı Sayı

Yıl 2023 Cilt: 8 Sayı: 1

Kaynak Göster

APA
Kavas, M., Atinkaya Baytemir, C., Alışık, M., Öztürk, A., Alparslan Bekir, S., Aydoğan Eroğlu, S., Ersöz Köse, E., Yalçınkaya, İ., & Erel, Ö. (2023). The Effect of Thiol-Disulfide Homeostasis on Prognosis in Patients with Early-Stage Non-Small Cell Lung Cancer. Online Turkish Journal of Health Sciences, 8(1), 122-126. https://doi.org/10.26453/otjhs.1226101
AMA
1.Kavas M, Atinkaya Baytemir C, Alışık M, vd. The Effect of Thiol-Disulfide Homeostasis on Prognosis in Patients with Early-Stage Non-Small Cell Lung Cancer. OTSBD. 2023;8(1):122-126. doi:10.26453/otjhs.1226101
Chicago
Kavas, Murat, Cansel Atinkaya Baytemir, Murat Alışık, vd. 2023. “The Effect of Thiol-Disulfide Homeostasis on Prognosis in Patients with Early-Stage Non-Small Cell Lung Cancer”. Online Turkish Journal of Health Sciences 8 (1): 122-26. https://doi.org/10.26453/otjhs.1226101.
EndNote
Kavas M, Atinkaya Baytemir C, Alışık M, Öztürk A, Alparslan Bekir S, Aydoğan Eroğlu S, Ersöz Köse E, Yalçınkaya İ, Erel Ö (01 Mart 2023) The Effect of Thiol-Disulfide Homeostasis on Prognosis in Patients with Early-Stage Non-Small Cell Lung Cancer. Online Turkish Journal of Health Sciences 8 1 122–126.
IEEE
[1]M. Kavas vd., “The Effect of Thiol-Disulfide Homeostasis on Prognosis in Patients with Early-Stage Non-Small Cell Lung Cancer”, OTSBD, c. 8, sy 1, ss. 122–126, Mar. 2023, doi: 10.26453/otjhs.1226101.
ISNAD
Kavas, Murat - Atinkaya Baytemir, Cansel - Alışık, Murat - Öztürk, Akın - Alparslan Bekir, Sümeyye - Aydoğan Eroğlu, Selma - Ersöz Köse, Elçin - Yalçınkaya, İrfan - Erel, Özcan. “The Effect of Thiol-Disulfide Homeostasis on Prognosis in Patients with Early-Stage Non-Small Cell Lung Cancer”. Online Turkish Journal of Health Sciences 8/1 (01 Mart 2023): 122-126. https://doi.org/10.26453/otjhs.1226101.
JAMA
1.Kavas M, Atinkaya Baytemir C, Alışık M, Öztürk A, Alparslan Bekir S, Aydoğan Eroğlu S, Ersöz Köse E, Yalçınkaya İ, Erel Ö. The Effect of Thiol-Disulfide Homeostasis on Prognosis in Patients with Early-Stage Non-Small Cell Lung Cancer. OTSBD. 2023;8:122–126.
MLA
Kavas, Murat, vd. “The Effect of Thiol-Disulfide Homeostasis on Prognosis in Patients with Early-Stage Non-Small Cell Lung Cancer”. Online Turkish Journal of Health Sciences, c. 8, sy 1, Mart 2023, ss. 122-6, doi:10.26453/otjhs.1226101.
Vancouver
1.Murat Kavas, Cansel Atinkaya Baytemir, Murat Alışık, Akın Öztürk, Sümeyye Alparslan Bekir, Selma Aydoğan Eroğlu, Elçin Ersöz Köse, İrfan Yalçınkaya, Özcan Erel. The Effect of Thiol-Disulfide Homeostasis on Prognosis in Patients with Early-Stage Non-Small Cell Lung Cancer. OTSBD. 01 Mart 2023;8(1):122-6. doi:10.26453/otjhs.1226101

Cited By

Creative Commons Lisansı
 

Online Türk Sağlık Bilimleri Dergisi Creative Commons Atıf-GayriTicari 4.0 Uluslararası Lisansı ile lisanslanmıştır.

Bu, Creative Commons Atıf Lisansı (CC BY-NC 4.0) şartları altında dağıtılan açık erişimli bir dergidir. Orijinal yazar(lar) veya derginin adı ve bu dergideki orijinal yayının kabul görmüş akademik uygulamaya uygun olarak atıfta bulunulması koşuluyla, diğer forumlarda kullanılması, dağıtılması veya çoğaltılmasına izin verilir. Bu şartlara uymayan hiçbir kullanım, dağıtım veya çoğaltmaya izin verilmez.

Makale gönderme süreçleri ve "Telif Hakkı Devir Formu" hakkında yardım almak için tıklayınız.